Cigna Group’s (CI) Outperform Rating Reaffirmed at Royal Bank Of Canada

Cigna Group (NYSE:CI)‘s stock had its “outperform” rating reissued by investment analysts at Royal Bank Of Canada in a research report issued on Thursday, Benzinga reports. They presently have a $337.00 price target on the health services provider’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 26.36% from the company’s current price.

A number of other research analysts have also issued reports on the company. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, September 26th. Piper Sandler decreased their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 3rd. Wells Fargo & Company increased their target price on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Evercore assumed coverage on Cigna Group in a research report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price on the stock. Finally, Guggenheim raised their price objective on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $337.10.

Cigna Group Stock Performance

NYSE CI traded down $5.13 during trading hours on Thursday, reaching $266.70. The stock had a trading volume of 531,304 shares, compared to its average volume of 1,676,637. The stock has a fifty day moving average of $279.53 and a 200 day moving average of $280.55. The stock has a market cap of $70.47 billion, a P/E ratio of 11.03, a price-to-earnings-growth ratio of 0.93 and a beta of 0.31. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The company had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the business earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Insider Activity

In other news, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 22,730 shares of company stock valued at $6,293,359. 0.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cigna Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CI. QRG Capital Management Inc. lifted its stake in Cigna Group by 35.1% in the second quarter. QRG Capital Management Inc. now owns 22,694 shares of the health services provider’s stock valued at $6,256,000 after buying an additional 5,902 shares during the last quarter. Envestnet Portfolio Solutions Inc. lifted its stake in Cigna Group by 45.9% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 19,015 shares of the health services provider’s stock valued at $5,242,000 after buying an additional 5,985 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in Cigna Group by 43.2% in the second quarter. Envestnet Asset Management Inc. now owns 676,904 shares of the health services provider’s stock valued at $186,609,000 after buying an additional 204,285 shares during the last quarter. Anchor Investment Management LLC lifted its stake in Cigna Group by 7.5% in the second quarter. Anchor Investment Management LLC now owns 3,224 shares of the health services provider’s stock valued at $889,000 after buying an additional 226 shares during the last quarter. Finally, Sequoia Financial Advisors LLC lifted its stake in Cigna Group by 14.8% in the second quarter. Sequoia Financial Advisors LLC now owns 12,092 shares of the health services provider’s stock valued at $3,333,000 after buying an additional 1,563 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and set a $337 price target, implying substantial upside from recent levels. The endorsement supports the view that Cigna’s valuation does not fully reflect its growth prospects.
• Positive Sentiment: At its investor day, Cigna introduced its “Lead to One” strategy, emphasizing complex care, specialty pharmacy, clinical expertise, data, technology and artificial intelligence. Management is targeting 10%–14% adjusted EPS compound annual growth through 2030, providing a potentially strong longer-term earnings narrative. The Cigna Group Hosts 2026 Investor Day
• Positive Sentiment: Cigna plans to invest $3 billion over multiple years to improve workflow, productivity and operating capabilities. Although the spending creates near-term execution risk, the company expects it to strengthen performance and support growth in specialty pharmacy and complex care. Cigna To Ramp Up Investments In Specialty Pharmacy And Complex Care
• Positive Sentiment: Cigna is expanding its international health benefits business through an exclusive agreement with UnitedHealthcare Global, potentially improving its global distribution and service capabilities. Cigna strengthens its international business with UnitedHealthcare
• Neutral Sentiment: Management reaffirmed its 2026 adjusted EPS outlook of $30.45, broadly consistent with expectations, while presenting the new long-term targets at investor day. Cigna Sets Long-Term Financial Targets
• Negative Sentiment: 2026 revenue guidance of $280 billion is below the $287.2 billion analyst consensus, while EPS guidance of $30.45 is slightly under the $30.51 consensus. The shortfall may be driving caution despite the company’s attractive long-term growth outlook.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.